View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
July 1, 2022

Magazine-How delays derailed Covid-19 vaccination in Africa

In this issue, we examine how delays derailed Covid-19 vaccination campaigns in Africa, China’s rapid progress in developing CAR-T therapies, how the bear market is affecting drug financing, and more.

By Manasi Vaidya

The latest issue of Pharma Technology Focus is out now. Read it for free on all devices.

Some months after the first Covid-19 vaccines became available, the World Health Organization (WHO) set a target of vaccinating 70% of each country’s population by the end of June 2022. Global trends indicate that initially, a slow supply did not allow African countries, in particular, to stay on pace to meet this target, and now vaccination rates have even begun to slow down. Given the deadline, we explore the current relevance and achievability of the WHO’s target, and why it proved challenging for some developing nations in Africa.  

Also in this issue, we take a look at efforts to tackle the opioid epidemic and how small biotechs and research labs appear to be at the forefront of innovative research in that domain.  

Don’t miss the data-led investigations into the demand for jobs in cybersecurity and big data in the pharmaceutical industry, and how artificial intelligence-led efforts in drug discovery may still only be at the start of a long development journey.  

Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry.

You can also subscribe here to receive email notifications when a new issue is available.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology